Detalhe da pesquisa
1.
Simulating Intestinal Transporter and Enzyme Activity in a Physiologically Based Pharmacokinetic Model for Tenofovir Disoproxil Fumarate.
Antimicrob Agents Chemother
; 61(7)2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28416547
2.
Securing accelerated access to long-acting injectable cabotegravir for HIV prevention in low- and middle-income countries.
J Int AIDS Soc
; 26 Suppl 2: e26101, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37439082
3.
Pediatric COVID-19 Therapeutics: Seizing the Right Research and Development Opportunities to Accelerate Access for Children.
Pediatr Infect Dis J
; 41(1): e1-e5, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34784302
4.
Advancing the prevention and treatment of HIV in children: priorities for research and development.
Lancet HIV
; 9(9): e658-e666, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35863362
5.
Adaption of an ongoing clinical trial to quickly respond to gaps in changing international recommendations: the experience of D2EFT.
HIV Res Clin Pract
; 23(1): 37-46, 2022 07 19.
Artigo
Inglês
| MEDLINE | ID: mdl-35938597
6.
Catalysing the development and introduction of paediatric drug formulations for children living with HIV: a new global collaborative framework for action.
Lancet HIV
; 5(5): e259-e264, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29739700
7.
Shortening the decade-long gap between adult and paediatric drug formulations: a new framework based on the HIV experience in low- and middle-income countries.
J Int AIDS Soc
; 21 Suppl 12018 02.
Artigo
Inglês
| MEDLINE | ID: mdl-29485727
8.
Antiretroviral dose optimization: the future of efavirenz 400âmg dosing.
Curr Opin HIV AIDS
; 12(4): 339-342, 2017 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-28570367
9.
Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate.
J Pharm Sci
; 106(3): 906-919, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-27986599